Last reviewed · How we verify
NCT06053294: CARB
Neural and Metabolic Factors in Carbohydrate Reward
NA trial testing CS- Beverage in Carbohydrate Metabolism in 64 participants. Currently enrolling.
1 May 2028
Quick facts
| Lead sponsor | Virginia Polytechnic Institute and State University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 64 |
| Start date | 1 May 2023 |
| Primary completion | 1 May 2028 |
| Estimated completion | 1 May 2029 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CS- Beverage
- CS+Fast
- CS+Slow
Conditions studied
- Carbohydrate Metabolism — all drugs for Carbohydrate Metabolism →
Sponsor
Virginia Polytechnic Institute and State University
Who can join
Adults 18 to 45, any sex, with Carbohydrate Metabolism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Dietary factors contributed to nearly 50% of all cardiometabolic deaths in the US in 2012, making it one of the leading causes of preventable death in the US, second only to tobacco use. Human diets and food choices can't help but be influenced by the ubiquitous availability of processed foods of high-energy density and low nutrient content, consumption of which can lead to obesity, type II diabetes, heart disease, and other types of metabolic dysfunction. Surprisingly, food reinforcement does not rely on perceived energy density. Rather food reinforcement is associated with actual energy density and therefore, on an implicit knowledge of caloric content. That implicit knowledge must have a neural signature and a mechanism by which the gut communicates nutritive value to the brain. There is evidence, at least for fat and carbohydrates, that these pathways are separable, but terminate in a common neural structure, the dorsal striatum or caudate. This could be one mechanism by which modern processed foods high in both fat and carbohydrate are so sought after and readily consumed, In fact, when experimentally tested, fat and carbohydrate combinations were more reinforcing calorie for calorie than fat or carbohydrates alone and the level of reinforcement correlated with activity in reward- related brain areas. Beyond simple reinforcing value, it is known from the literature on drugs of abuse that the faster a drug is arrives at the brain, the higher it's abuse potential, however, little is known about how the kinetics of nutrient excursion influence food preference, choice, and brain activity. This project aims to test this specifically for carbohydrate reward.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Neural and metabolic factors in carbohydrate reward: Rationale, design, and methods for a flavor-nutrient learning paradigm in humans.
Kelly AL, Baugh ME, Ahrens ML, Valle AN, et al · · 2024 · PMID 39413990 · DOI 10.1016/j.cct.2024.107717
Verify or expand the search:
- PubMed search for NCT06053294
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Virginia Polytechnic Institute and State University trials
Trials by the same sponsor.
- NCT07521072 — Testing an Intervention for College Students With Food Insecurity and Binge Eating · EARLY_PHASE1 · not yet recruiting
- NCT07042373 — Effects of Tobacco Abuse Liability-dependent Taxes in the ETM · NA · not yet recruiting
- NCT07158749 — Generalized and Domain-Specific Episodic Thinking for Smoking Cessation · NA · not yet recruiting
- NCT07457710 — Remote Haptic Rehabilitation for Parkinson's Disease · NA · not yet recruiting
- NCT05103514 — The Longitudinal Impact of SES and the CNDS on Recovery From SUD · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06053294 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Virginia Polytechnic Institute and State University
- Last refreshed: 11 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06053294.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing